TrialCancer science2021

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).

Masaki Ri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.